Source: Eur Respir Rev 2013; 22: 20-25
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Andrew Peacock. Pulmonary hypertension. Eur Respir Rev 2013; 22: 20-25

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics Source: Eur Respir J 2005; 25: 783-788 Year: 2005 Survival in pulmonary hypertension in Spain: insights from the Spanish registry}, Source: Eur Respir J 2012; 40: 596-603 Year: 2012 An epidemiological study of pulmonary arterial hypertension Source: Eur Respir J 2007; 30: 104-109 Year: 2007 Novel treatment for pulmonary vascular disease: lessons from pathophysiology Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases Year: 2006 Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology Source: Eur Respir Rev 2009; 19: 59-63 Year: 2010 Pulmonary arterial hypertension: genetics, reversibility testing and follow-up Source: ISSN=1025-448x, ISBN=1-904097-31-6, page=33 Year: 2004 Update on current treatment options of pulmonary hypertension Source: Annual Congress 2006 - Pulmonary hypertension at the crossroads of science and clinical medicine Year: 2006 Pulmonary hypertension: pathophysiology and diagnosis Source: Annual Congress 2007 - PG19 - Pulmonary vascular disorders: diagnosis and treatment Year: 2007 Riociguat for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Real-life data from the EXPERT registry Source: International Congress 2015 – Pulmonary hypertension: new treatment insights Year: 2015 A USA-based registry for pulmonary arterial hypertension: 1982 2006 Source: Eur Respir J 2007; 30: 1103-1110 Year: 2007 microRNA profile in COPD patients with and without pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH Year: 2015 End points in pulmonary arterial hypertension: the way forward Source: Eur Respir J 2004; 23: 947-953 Year: 2004 Immunity in idiopathic pulmonary arterial hypertension (IPAH), a role for activated DCs? Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 The prevalence and characteristics of pulmonary hypertension in severe COPD Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Chronic thromboembolic pulmonary hypertension Source: Eur Respir Mon 2012; 57: 108-118 Year: 2012 The French registry of pulmonary arterial hypertension in children: characteristics at diagnosis Source: Annual Congress 2007 - Clinical aspects of pulmonary arterial hypertension Year: 2007 The role of right heart catheterization prior to initiation of PAH specific therapy Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 How to detect disease progression in pulmonary arterial hypertension Source: Eur Respir Rev 2012; 21: 40-47 Year: 2012 The burden of pulmonary hypertension Source: Annual Congress 2006 - The burden of pulmonary hypertension Year: 2006